Department of Pediatrics, Nicklaus Children's Hospital, Miami, FL, USA.
Heart Center, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
Heart Fail Rev. 2023 Sep;28(5):1023-1031. doi: 10.1007/s10741-023-10319-0. Epub 2023 May 24.
Endocardial fibroelastosis (EFE) is a rare cardiac condition characterized by excessive endocardial thickening secondary to fibroelastic tissues that commonly present in infants and young children. Most of endocardial fibroelastosis cases are secondary forms, which occur in conjunction with other cardiac diseases. Endocardial fibroelastosis has been associated with poor prognosis and outcomes. In light of recent advancements in understanding pathophysiology, several new data have revealed compelling evidence that abnormal endothelial-to-mesenchymal transition is the root cause of endocardial fibroelastosis. This article aims to review the recent development in pathophysiology, diagnostic workup, and management, and to discuss possible differential diagnoses.
心内膜弹力纤维增生症(EFE)是一种罕见的心脏疾病,其特征为心内膜过度增厚,继发于纤维弹性组织,常见于婴儿和幼儿。大多数心内膜弹力纤维增生症为继发性,常与其他心脏疾病相关。心内膜弹力纤维增生症的预后和结局较差。鉴于对病理生理学认识的最新进展,一些新的数据揭示了令人信服的证据,即异常的内皮到间充质转化是心内膜弹力纤维增生症的根本原因。本文旨在综述心内膜弹力纤维增生症的病理生理学、诊断评估和治疗的最新进展,并讨论可能的鉴别诊断。